Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Thymosin β4 and VEGF are important for blood vessel formation in many organs.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

More public health efforts are needed to raise awareness and improve management of thyroid disorders.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Combination therapy with cyclosporine and low-dose corticosteroid shows favorable long-term results for treating alopecia areata.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Both Ayurvedic treatments improved hair fall, with Shirodhara being especially effective.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Thyroid hormone (T3) may reverse gray hair by stimulating hair growth.

308 nm excimer lamp therapy is effective for alopecia areata but less so for severe cases.

Using a specific laser and platelet-rich plasma together can effectively improve hair thickness and density in men with hair loss, without serious side effects.

New therapies are being developed that target integrin pathways to treat various diseases.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Hypothyroidism may increase the risk of nonmelanoma skin cancer.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.